Cabaletta Bio is trading $1.60, up 5.25%, after hours; no clear company-specific announcement explains the increase.
- The regular session closed at $1.52, down 1.30%.
- The latest company press release located was dated October 5.
- The rise contrasts with a weak broader market. Reuters reported technology-led declines on October 22 amid renewed worries about AI spending and geopolitical oil-market risks; available evidence does not establish those pressures as the reason for Cabaletta Bioβs move.